The “Brescia panel” (Claudin‐4 and BRCA‐associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas

Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma

(2020) Masanori Matsuda et al.   PATHOLOGY RESEARCH AND PRACTICE

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma

(2020) David B. Chapel et al.   Translational Lung Cancer Research

Claudin-4 shows superior specificity for mesothelioma vs non–small-cell lung carcinoma compared with MOC-31 and Ber-EP4

(2020) Julia R. Naso et al.   HUMAN PATHOLOGY

Claudin‐4 immunohistochemistry is a useful pan‐carcinoma marker for serous effusion specimens

(2019) Melissa Vojtek et al.   CYTOPATHOLOGY

Recent Advances in the Diagnosis of Malignant Mesothelioma

(2018) Sara Monaco et al.   ADVANCES IN ANATOMIC PATHOLOGY

Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma

(2018) Raghavendra Pillappa et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

(2018) Aliya Noor Husain et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

The role of BRCA1-associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine-needle aspiration cytology

(2018) Layla Hatem et al.   DIAGNOSTIC CYTOPATHOLOGY

Loss of BRCA1-associated protein 1 ( BAP1 ) expression is rare in non–small cell lung cancer

(2017) Daniel Owen et al.   HUMAN PATHOLOGY

BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas

(2016) Harry C. Hwang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study

(2016) Luisella Righi et al.   Journal of Thoracic Oncology

The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification

(2016) Francoise Galateau-Salle et al.   Journal of Thoracic Oncology

Pathology analysis for mesothelioma study in the United Kingdom: Current practice and historical development

(2016) B. W. Case   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma

(2016) Michele Carbone et al.   Oncotarget

BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations

(2015) Brandon S. Sheffield et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication

(2015) A. Hjerpe et al.   CYTOPATHOLOGY

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

(2015) Stephanie M. McGregor et al.   HUMAN PATHOLOGY

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations

(2015) Marta Cigognetti et al.   MODERN PATHOLOGY

Claudins: Gatekeepers of lung epithelial function

(2015) Barbara Schlingmann et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Germline BAP1 mutations predispose to malignant mesothelioma

(2011) Joseph R Testa et al.   NATURE GENETICS

Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions

(2010) Silvia Lonardi et al.   DIAGNOSTIC CYTOPATHOLOGY

Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma

(2009) Jason L. Hornick et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY